Capnography Devices Market Size By Product (Hand-held, Stand-alone, Multi-parameter), By Technology (Side Stream, Main Stream, Micro Stream), By Component (Original Equipment Manufacturer (OEM) Modules), By Application (Emergency Medicine, Critical Care, Procedural Sedation, Pain Management), By End-use (Hospitals, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Sep 2021  |  Report ID: GMI2922  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 250   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Capnography Devices Market size surpassed USD 520 million in 2020 and is estimated to grow at a CAGR of over 7.4% between 2021 and 2027. Rising prevalence of respiratory disorders has led to an upsurge in surgical interventions, thereby propelling the demand for capnography devices to confirm that the pulmonary circulation is unobstructed and to observe the changes of end-tidal carbon dioxide pressure. The use of these devices offers better patient compliance as well as aids in monitoring patients during general anaesthesia.
 

Capnography Devices Market Overview

Get more details on this report - Request Free Sample PDF
 

Capnography devices have emerged as a preferred choice in the monitoring of malignant airway lesions due to satisfactory clinical outcomes. Growing conscience among the people suffering from central airway obstruction, chronic obstructive pulmonary disease (COPD), lung cancer, and asthma regarding the availability of minimally invasive procedures with lowered adverse effects is boosting the acceptance of effective and non-invasive methods of monitoring called capnography.
 

However, a lack of skilled professionals with technical expertise to use capnography instruments may have a negating impact on the market growth. Capnography devices are complex in nature and thus need trained operators to handle them. Shortage of skilled staff, specifically in developing nations may limit the use of these devices. Furthermore, the high cost associated with certain capnography devices may further obstruct the market expansion. Moreover, the U.S. FDA closely monitors the development of these devices and approves commercialization based on their performance.
 

The emergence of COVID-19 is an unprecedented public health concern and has led to an increased number of hospitalizations. The outbreak of the coronavirus pandemic has infected millions of people across the globe. As per the meta-analysis of seven studies, the researchers concluded that people with severe COPD may have a higher risk of COVID-19 complications as COVID-19 affects the respiratory system. Thus, in early 2020, the unprecedented effect of COVID-19 had a moderate impact on practices for airway management treatments as all the elective procedures across the globe had been postponed.
 

However, with the formulation of policies and standards to assure the safety of the patient, the number of procedures continued to increase again. Thus, in response to COVID-19, the healthcare system is rapidly restructuring practices for airway obstruction to ensure that patients receive essential care while minimizing exposure to COVID-19 infection. Therefore, the market is predicted to experience considerable growth in the coming years with a decreasing number of COVID-19 patients in some regions and beneficial government protocols.
 

Rising number of respiratory diseases is set to propel the capnography devices market progression

Growing number of people suffering from respiratory diseases globally is one of the prime factors stimulating the industry growth. As per the article published in the National Centre for Biotechnology Information (NCBI), it is slated that by 2035, the number of lung cancer deaths in the world will rise by 86% and in some regions, the number of lung cancer deaths will double that includes America, Western Pacific, and South-East Asia region. This highlights the surging need for capnography instruments to diagnose early airway disorders and respiratory depression, particularly during sedation, leading to a reduction in severe complications. Additionally, factors such as tobacco smoking, family hereditary of lung cancer, and air pollution among others are projected to foster the escalating cases of patients suffering from respiratory diseases across the globe.
 

Several advantages offered by hand-held capnography devices is expected to drive the preference for these instruments

 The hand-held segment in the capnography devices market was valued at USD 267 million in 2020 led by the numerous advantages offered by hand-held capnography instruments. These hand-held devices are manufactured to suit each patient’s condition and doctor’s specific preference to enable accurate movement of the instrument. These devices are easy to handle and highly portable to measure the carbon dioxide content of inspired and expired air. The battery-operated design of hand-held capnography devices provides the flexibility to accommodate both stationary & transport applications and mobile spot-checking. It delivers a broad range of movement and effortless positioning with a compact designing. Recently developed hand-held capnography devices come with a visual & audible alarm and side stream technology that accommodates both intubated & non-intubated patients.
 

Factors such as non-invasive and diverting nature will promote the adoption of side stream devices

The side stream segment accounted for 48% of the capnography devices market share in 2020 impelled by the use of side stream capnography instruments in a broad range of applications and the ability to perform capnography through a non-invasive & diverting method. Cost-effective operating, less maintenance, effectivity, and accuracy are some of the factors promoting the demand for side stream capnography devices. In addition, the development and commercialization of innovative side stream capnography instruments by several participants in the industry will augment the acceptance of these devices. Side stream capnography is widely used in non-intubated patients attributed to its non-invasive nature. It also delivers suitable quantitative bedside data related to ventilation-perfusion mismatching and uneven alveolar emptying.
 

Increasing usage of original equipment manufacturer (OEM) modules is poised to stimulate the capnography devices market demand

The original equipment manufacturer (OEM) modules segment exceeded USD 234 million in 2020. An original equipment manufacturer (OEM) sells the components of capnography instruments to a firm so that it resells those devices to its specific consumers under its brand name. For instance, Covidien (Medtronic) has developed a Microstream MicroPod OEM module for its equipment manufacturer (OEM) partners to detect changes associated with ensuing respiratory failure.  Players operating in the market are emphasized to incorporate these OEM modules in their capnography instruments that aids healthcare facilities enhance patient safety by increasing access to capnography technology. Medtronic’s Microstream microMediCO? OEM module can be designed into a wider range of host configurations that measures etCO2, FiCO2, and respiration rate even in non-intubated patients.
 

Growing use of capnography technology among critically ill patients will spur the market value

The critical care segment is slated to reach USD 185 million by 2027 owing to the requirement of real-time monitoring and accurate measurement in the healthcare setting among critically ill patients. In the critical care unit, capnography devices deliver several benefits pertaining to monitoring of respiratory & cardiovascular function and airway management. Additionally, they diagnose displaced tracheostomy & tracheal tubes to detect inadvertent oesophageal intubation.
 

Several benefits provided by hospitals in the monitoring of patients with respiratory diseases are projected to accelerate the industry progression

Capnography Devices Market Size

Get more details on this report - Request Free Sample PDF
 

The hospitals end-use segment in the capnography devices market captured USD 285 million in 2020. The enhanced healthcare infrastructure of hospitals, surging number of multispecialty hospitals coupled with a growing number of surgeries for respiratory diseases is driving the segment revenue worldwide. Public and private organizations in developed regions are focusing on investing in the healthcare area, hence, the hospital segment will upsurge positively during the forecast timeframe. The easy availability of advanced technologies surges the demand for capnography devices among medical professionals in hospitals to simplify the patient monitoring by enabling clinicians to measure end-tidal CO2 and several vital signs with the same machine. This further allows pulmonologists to diagnose respiratory diseases efficiently. The adoption of innovative patient diagnostic systems to enhance patient care in hospitals is predicted to fuel the patient preference for hospitals.
 

Rising prevalence of respiratory disorders in the North America region will influence the industry expansion

Global Capnography Devices Market

Get more details on this report - Request Free Sample PDF
 

U.S. dominated the North America capnography devices market in 2020 and is anticipated to cross USD 395 million by 2027 due to the growing prevalence of respiratory disorders. As stated by the Centers for Disease Control and Prevention, cigarette smoking is the major factor for lung cancer and in the U.S. cigarette smoking is linked to about 80% to 90% of lung cancer deaths. It is estimated that the impact of this disease will continue to rise in the following years attributed to the sedentary lifestyles and the acceptance of unhealthy habits. Moreover, as reported by the American Cancer Society, secondhand smoke is considered to cause over 7,000 deaths from lung cancer each year in the U.S. Furthermore, in 2019, the prevalence of asthma among adults age above 18 years was approximately 20,026,722 in the country. With the rising disease burden, the number of treatment procedures is also increasing that will further drive the capnography instruments demand in the coming years.
 

Strategies implemented by major players are expected to generate business opportunities in the market

Some of the major companies operating in the market are Dragerwerk AG & CO. KGaA, Masimo Corporation, Medtronic, Nihon Kohden, Smiths Medical and Phillips Healthcare among others. Major leaders are adopting strategic initiatives such as forward integration, research collaborations and new product development in order to generate maximum revenue share and promote company growth.
 

Recent industry developments:

  • In April 2021, Masimo Corporation announced the U.S. FDA approval for Radius PCG. It is a portable real-time capnograph with wireless Bluetooth connectivity that provides seamless, tetherless mainstream capnography for patients of all ages. This approval helped the company to gain competitive edge and bolster its industrial position.
     
  • In May 2020, Philips Healthcare and Masimo Corporation announced the partnership to bring innovations in patient monitoring solutions including capnography devices, thereby offered new opportunities to design highly effective instruments for capnography.
     

Capnography devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product, 2016 - 2027 (USD Million)

  • Hand-held
  • Stand-alone
  • Multi-parameter

Market, By Technology, 2016 - 2027 (USD Million)

  • Side Stream
  • Main Stream
  • Micro Stream

Market, By Component, 2016 - 2027 (USD Million)

  • Original Equipment Manufacturer (OEM) Modules
  • Others

Market, By Application, 2016 - 2027 (USD Million)

  • Emergency Medicine
  • Critical Care
  • Procedural Sedation
  • Pain Management
  • Others

Market, By End-use, 2016 - 2027 (USD Million)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea 
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Frequently Asked Questions (FAQ) :

The capnography devices industry size exceeded USD 520 million in 2020 and will grow at a CAGR of 7.4% from 2021 to 2027.
Hand-held devices recorded USD 267 million in 2020 and will depict substantial growth due to their ease of handling and high portability.
Side stream instruments registered more than 48% share in 2020 and will grow owing to their ability to perform capnography through a non-invasive and diverting method.
In North America, the U.S. will witness a revenue of USD 395 million through 2027 driven by the surging prevalence of respiratory disorders.

Premium Report Details

  • Published Date: Sep 2021
  • Pages: 250
  • Tables: 288
  • Charts / Figures: 19
  • Companies covered: 10
  • Countries covered: 18

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X